# US 2022/0276245 A1 · Test system for recognizing legionellae

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0276245 A1
- Document ID: US20220276245A1
- Status: Published application
- Kind: A1
- Application number: 17/633,791
- Filed: 2020-08-10
- Published: 2022-09-01
- Earliest claimed: 2019-08-09
- Assignees: Securetec Detektions-Systeme AG; Technische Universität München
- Applicants: Securetec Detektions-Systeme AG; Technische UniversitäT MüNchen
- Inventors: Torsten STADTHAGEN; Patrick GRUBER; Hannelore MEYER; Nina WANTIA
- Web page: https://patentgrep.com/patent/US20220276245A1

## CPC

- G01N 33/56911: {Bacteria}
- G01N 33/54388: {based on lateral flow}
- G01N 2469/10: Detection of antigens from microorganism in sample from host
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present disclosure relates to a test system for identifying legionellae. Furthermore, the present disclosure relates to a test system for detecting an infection with legionellae, and to the use of a test system in a method for detecting legionellae. The disclosure further relates to a method for detecting an infection with legionellae.

## Claims

### Claim 1

A test system for the identifying legionnaires' disease.

### Claim 2

A test system for detecting infection of a subject with legionellae.

### Claim 3 (depends on 1)

The test system according to claim 1, wherein the test system is or comprises a lateral flow test (LFT).

### Claim 4 (depends on 1)

The test system according to claim 1, wherein the test system is set up to identify legionnaires' disease and/or to detect an infection with legionellae in saliva or sputum.

### Claim 5 (depends on 4)

The test system according to claim 4, wherein the identification and/or detection takes place at least partially via the binding of at least one protein to a specific binding partner.

### Claim 6 (depends on 5)

The test system according to claim 5, wherein the at least one protein is a protein of the species Legionella pneumophila, Legionella micadei, Legionella bozmanii, Legionella dumoffii and/or Legionella longbeachae.

### Claim 7 (depends on 6)

The test system according to claim 6, wherein the at least one or also several proteins comprises MIP and/or PAL and/or FLA.

### Claim 8 (depends on 5)

The test system according to claim 5, wherein the test system comprises:
a) a test element with microfluidic structures comprising:
(i) a first region set up to absorb eluent,
(ii) a second region set up for the application of a sample,
(iii) a third region set up for detecting the protein
(iv) a fourth region set up for absorbing excess eluent, and
b) a housing.

### Claim 9 (depends on 8)

The test system according to claim 8, wherein the test element comprises a further region, the further region at least temporarily comprising the specific binding partner for the protein.

### Claim 10 (depends on 1)

The test system according to claim 1, wherein the test system further comprises a control system.

### Claim 11 (depends on 5)

The test system according to claim 5, wherein the test system further comprises a sampling element set up for receiving a sample containing the at least one protein.

### Claim 12 (depends on 1)

A use of a test system according to claim 1 for detecting an infection with legionellae.

### Claim 13

A method for detecting legionellae in a sample, comprising the following steps:
(a) providing a test system,
(b) applying the sample to a test element, and
(c) detecting the presence of at least one protein in the sample, wherein
the test system comprises at least one specific binding partner, to which the at least one protein binds,
wherein the detection is at least partly effected via the binding of the at least one protein to the specific binding partner.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the sample comprises a saliva sample or sputum.

### Claim 15 (depends on 13)

The method according to claim 13, wherein the specific binding partner comprises a monoclonal antibody, polyclonal antibody, affinity-purified antibody, antibody fragment, peptide, protein, nanobody, nucleic acid fragment, aptamer, anticalin, lectin, affibody and/or chemical ligand, the specific binding partner being linked to a labeling element.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the labeling element comprises at least one dye, fluorochrome, fluorophore, luminophore, enzyme, peptide, biotin, oligonucleotide, protein tag, radioactive isotope, non-radioactive nuclide, nanoparticle.

### Claim 17 (depends on 13)

The method according to claim 13, wherein the specific binding partner is available in soluble form and/or dried.

### Claim 18 (depends on 5)

The test system according to claim 5, wherein the at least one binding protein is a protein of the bacterial genus Legionella.

### Claim 19 (depends on 8)

The test system according to claim 8, wherein the test element a test element with microfluidic structures is a chromatographic test strip and wherein the third region is set up for optically detecting the proteins of MIP, PAL and/or FLA.

### Claim 20 (depends on 10)

The test system according to claim 10, wherein the control system is an optical control system.

### Claim 21 (depends on 15)

The labeling element according to claim 15, wherein the nanoparticle is gold nanoparticle, fluorescent nanoparticle, magnetic nanoparticle and/or quantum dot.
